Feature | March 27, 2013

Biotronik Iforia is World’s First DF4 ICD/CRT-D Approved for MRI

First implantations of the device taking place worldwide

Biotronik Iforia ICD/CRT-D CE-Approval

March 27, 2013 — Biotronik received CE mark for its most advanced ICD/CRT-D (implantable cardioverter defibrillator/cardiac resynchronization therapy device) series. Iforia is the world’s first DF4 ICD/CRT-D series approved for MRI (magnetic resonance imaging). In addition it contains one of the world’s smallest ICDs, the Iforia single chamber ICD.

Aside from featuring ProMRI technology, which allows patients to undergo potentially life-saving MRI scans, Iforia also includes the industry standard DF4 connector system, which is designed to simplify and shorten the implantation procedure. The DF4 connector combines the traditional three connectors into one, allowing for a more convenient implantation procedure without compromising safety.

One of the first implanters, Ching Chi Keong, M.D., of National Heart Centre Singapore, said, “With the Iforia series I can provide my patients with a small and highly reliable ICD and CRT-D series. It includes an impressive range of state-of-the-art innovations including ProMRI and home monitoring. In addition the DF4 technology simplifies the implantation procedure, while the small size of the device makes it more comfortable for the patient and also leads to a better cosmetic result.”

The Iforia series is one of the smallest ICDs and CRT-Ds on the market. In addition the Iforia single chamber ICD has a longevity of more than 11 years and the Iforia CRT-D of more than seven years. This allows for a low replacement rate, benefitting both patients and the healthcare system.

“Safety and reliability are the foundation of all of our new technologies and innovations,” said Christoph Böhmer, president international of Biotronik. “Iforia offers enhanced diagnostic possibilities with the highest reliability and unsurpassed longevity... The new Iforia series combined with ProMRI and Biotronik Home Monitoring offers physicians and patients the best combination of reliability and innovation.”

The European market release of the Iforia series is expected in mid-2013. The first implanters of Biotronik's Iforia ICDs and CRT-Ds are:

  • Prof. Dr. Steffen Behrens, Vivantes Humboldt Hospital Berlin, Germany;
  • Ching Chi Keong, M.D., National Heart Centre Singapore, Singapore;
  • Dr. Thomas Faber, University Heart Centre Freiburg, Germany;
  • Prof. Dr. Stephan B. Felix and Dr. Mathias Busch, University Hospital Greifswald, Germany;
  • Dr. Peter Lercher and Dr. Günther Prenner, LKH-University Clinic Graz, Austria;
  • Abdulmohsen al Musaad, M.D., National Guard Health Affairs Hospital, Riyadh, Saudi Arabia;
  • Dr. Antti Ylitalo and Dr. Tuomas Paana, Satakunta Central Hospital, Pori, Finland.


For more information: www.biotronik.com

Related Content

Sponsored Content | Videos | Inventory Management| September 21, 2016
With bundled payments putting increased pressure on hospitals to manage supply costs while providing quality patient
Medtronic, CRT, cardiac resynchroniazation therapy devices, heart failure, medication adherence, retrospective analysis, HFSA 2016
News | Heart Failure| September 20, 2016
Medtronic plc announced the results of an analysis that reveals patients increasingly adhere to heart failure...
don woodlock, GE Healthcare, EP CVIS, electrophyiology
Sponsored Content | Webinar | Cardiac PACS| September 16, 2016
Cardiac rhythm management (CRM) data is becoming increasingly important in the management of patients with implantabl
EBR Systems, FDA, WiSE Technology, Wireless Stimulation Endocardially, SOLVE-CRT study

The WiSE CRT System uses a tiny implant in the left ventricle to synchronize the heart, overcoming limitations of traditional cardiac resynchronization therapy (CRT) in heart failure patients. Graphic courtesy of Business Wire.

News | Cardiac Resynchronization Therapy Devices (CRT)| September 15, 2016
EBR Systems Inc. announced the U.S. Food and Drug Administration (FDA) has granted an Investigational Device Exemption...
Sponsored Content | Videos | Heart Failure| September 02, 2016
The Respicardia Remede System is a pacemaker-like implantable device designed to improve cardiovascular health by res
Respicardia, Remede, pacemaker for sleep apnea, central sleep apnea treatment

The Respicardia Remede System is a pacemaker-like implantable device designed to improve cardiovascular health by restoring natural breathing during sleep in patients with central sleep apnea.

News | Heart Failure| September 02, 2016
September 2, 2016 — Results from an international, randomized study show that an implanted nerve stimulator significa
News | Cardiac Resynchronization Therapy Devices (CRT)| August 30, 2016
August 30, 2016 — Medtronic plc announced results from the...
Medtronic, Micra TPS pacemaker, transcatheter pacing system, global clinical trial, one-year results, ESC 2016
News | Pacemakers| August 29, 2016
August 29, 2016 — Medtronic plc announced new long-term results from the Medtronic Micra Transcatheter Pacing System
Merlin, Merlin@home, SJM, St. Jude Medical Merlin, cybersecurity

St. Jude Medical said recent claims of the cyber attack vulnerability of its [email protected] remote monitoring system and its implantable EP devices are not true.

Feature | EP Lab| August 29, 2016 | Dave Fornell
August 29, 2016 — Investment research firm Muddy Waters Capital released a report Aug. 25 saying it believes St.
Overlay Init